CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
BinaxNOW Test +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05105789
NCT05105789N/ACompleted
CompareCT.gov

Safe and Healthy Schools

University of Wisconsin, Madison·interventional·Posted Nov 3, 2021·Updated May 22, 2024

In Brief

A clinical study evaluating BinaxNOW Test and "Lollipop" swab for Sars-CoV-2 Infection and COVID-19. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This study will target Madison Metropolitan School District (MMSD) school children ages 4-19 and staff who have not had a previous positive COVID-19 test within the past 3 months. It will enroll children and adults for 1-3 days to explore whether serial "at-home" BinaxNOW testing is feasible and non-inferior to "at school" single PCR testing for the evaluation of symptomatic individuals with a negative initial BinaxNOW. It will also explore whether lollipop swabs are more acceptable and perform as well as nasal swabs with polymerase chain reaction (PCR) testing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSars-CoV-2 Infection, COVID-19
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 3, 2021
Enrollment StartOct 11, 2021
Primary CompletionMay 21, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.7 years ago

Interventions

BinaxNOW Testother

diagnostic test for SARS-CoV-2

"Lollipop" swabother

A lollipop swab, is an oral swab to collect saliva, sucked on like a lollipop for 20 seconds.